Amgen leadership joins Patients as Partners to discuss their RISE (Representation in Clinical Research) Initiative that is transforming clinical trial diversity at Amgen. Key topics include:

The development of RISE, what it took to get off the ground

Working with internal global development operations and other key groups by diversifying investigators and collaborating with those who serve diverse patient areas at clinical trial sites

Collaborations with non-profits in communities that can help remove barriers to participation in clinical trials

Partnering with influential community leaders to regain trust within communities

Key learnings to help other stakeholders adapt, adjust and build on their current diversity and community engagement initiatives

Ponda Motsepe-Ditshego, MBChB, VP, Global Medical Therapeutic Area Head, General Medicine & Global Chair, Amgen Black Employee Network (ABEN), Amgen

Jude Ngang, PharmD, Executive Director, Representation in Clinical Research (RISE), Amgen

Moderated by:

Hassan Kadim, Director, Head of Clinical Trial Business Capabilities, Global Development Operations, BMS

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

How Amgen is RISING Above with Clinical Trial Diversity

Share

Embed